Showing 6141-6160 of 8875 for: Cochrane Systematic Reviews Back
- Pharmacological treatment for memory disorder in multiple sclerosis
Cochrane Systematic Reviews, 16-Dec-2013
This is an update of the Cochrane review "Pharmacologic treatment for memory disorder in multiple sclerosis" (first published in The Cochrane Library 2011, Issue 10).
- Pharmacological treatment for pain in Guillain‐Barré syndrome
Cochrane Systematic Reviews, 9-Apr-2015
Pain in Guillain-Barré syndrome (GBS) is common, yet it is often under recognised and poorly managed. In recent years, a variety of pharmacological treatment options have been investigated in clinical trials for people with GBS-associated pain. This is an
- Pharmacological treatment for psychotic depression
Cochrane Systematic Reviews, 7-Dec-2021
Evidence is limited regarding the most effective pharmacological treatment for psychotic depression: monotherapy with an antidepressant, monotherapy with an antipsychotic, another treatment (e.g. mifepristone), or combination of an antidepressant plus an
- Pharmacological treatment of children with gastro‐oesophageal reflux
Cochrane Systematic Reviews, 24-Nov-2014
Gastro-oesophageal reflux (GOR) is a common disorder, characterised by regurgitation of gastric contents into the oesophagus. GOR is a very common presentation in infancy in both primary and secondary care settings. GOR can affect approximately 50% of inf
- Pharmacological treatment of depression in people with a primary brain tumour
Cochrane Systematic Reviews, 17-Jul-2020
This is the second updated version of the Cochrane Review published in Issue 3, 2010 and first updated in Issue 5, 2013.
- Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
Cochrane Systematic Reviews, 24-May-2021
This is an update of a Cochrane Review first published in 2006 (McGuinness 2006), and previously updated in 2009 (McGuinness 2009). Hypertension is a risk factor for dementia. Observational studies suggest antihypertensive treatment is associated with low
- Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm
Cochrane Systematic Reviews, 12-Jan-2017
Pharmacological prophylaxis has been proven to reduce the risk of cardiovascular events in individuals with atherosclerotic occlusive arterial disease. However, the role of prophylaxis in individuals with abdominal aortic aneurysm (AAA) remains unclear. S
- Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain‐Barré syndrome
Cochrane Systematic Reviews, 25-Jan-2020
Plasma exchange and intravenous immunoglobulin, but not corticosteroids, are beneficial in Guillain-Barré syndrome (GBS). The efficacy of other pharmacological agents is unknown. This review was first published in 2011 and previously updated in 2013, and
- Pharmacological treatments for fatigue associated with palliative care
Cochrane Systematic Reviews, 30-May-2015
This review updates the original review, 'Pharmacological treatments for fatigue associated with palliative care' and also incorporates the review 'Drug therapy for the management of cancer-related fatigue'.
- Pharmacological treatments for Friedreich ataxia
Cochrane Systematic Reviews, 30-Aug-2016
Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties. It is associated wit
- Pharmacological treatments for preventing epilepsy following traumatic head injury
Cochrane Systematic Reviews, 29-Jul-2015
Head injury is a common event and can cause a spectrum of motor and cognition disabilities. A frequent complication is seizures. Antiepileptic drugs (AED) such as phenytoin are often used in clinical practice with the hopes of preventing post-traumatic ep
- Pharmacological treatments for psychosis‐related polydipsia
Cochrane Systematic Reviews, 18-Oct-2006
Polydipsia is the intake of more than three litres of fluids per day. Primary polydipsia occurs when excessive drinking cannot be explained by an identified medical condition, and is not secondary to polyuria. The prevalence of this problem in psychiatric
- Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
Cochrane Systematic Reviews, 11-May-2020
Depression is an important consequence of stroke that influences recovery yet often is not detected, or is inadequately treated. This is an update and expansion of a Cochrane Review first published in 2004 and previously updated in 2008.
- Pharmacological, psychological, and non‐invasive brain stimulation interventions for treating depression after stroke
Cochrane Systematic Reviews, 28-Jan-2020
Depression is an important morbidity associated with stroke that impacts on recovery yet often undetected or inadequately treated. This is an update and expansion of a Cochrane Review first published in 2004 and updated in 2008.
- Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis
Cochrane Systematic Reviews, 4-Nov-2016
Deep venous thrombosis (DVT) occurs in approximately one in 1000 adults every year, and has an annual mortality of 14.6%. In particular, iliofemoral DVT can lead to recurrent thrombosis and post-thrombotic syndrome (PTS), a painful condition which can lea
- Pharmacotherapies for cannabis dependence
Cochrane Systematic Reviews, 28-Jan-2019
Globally, cannabis use is prevalent and widespread. There are currently no pharmacotherapies approved for treatment of cannabis use disorders.
- Pharmacotherapies for sleep disturbances in dementia
Cochrane Systematic Reviews, 15-Nov-2020
Sleep disturbances, including reduced nocturnal sleep time, sleep fragmentation, nocturnal wandering, and daytime sleepiness are common clinical problems in dementia, and are associated with significant carer distress, increased healthcare costs, and inst
- Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis
Cochrane Systematic Reviews, 17-Jun-2019
Hepatic encephalopathy is a common complication of cirrhosis, with high related morbidity and mortality. Its presence is associated with a wide spectrum of change ranging from clinically obvious neuropsychiatric features, known as 'overt' hepatic encephal
- Pharmacotherapy and psychotherapy for body dysmorphic disorder
Cochrane Systematic Reviews, 21-Jan-2009
Body dysmorphic disorder (BDD) is a prevalent and disabling preoccupation with a slight or imagined defect in appearance. Trials have investigated the use of serotonin reuptake inhibitors (SRIs) and cognitive behaviour therapy (CBT) for BDD.
- Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
Cochrane Systematic Reviews, 2-Nov-2008
A large proportion of patients with anxiety disorders fail to respond to first-line medication interventions, despite evidence of the effectiveness of these agents.
